Discover 2,576 paid clinical trials in Illinois. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Illinois offers various clinical research options, including those for healthy volunteers interested in paid studies, as well as for individuals with specific health conditions. Leading research centers in Chicago, Plainfield, and Springfield are actively seeking participants, providing access to innovative treatments and personalized care.
Filter
1
Filter results
Results: 2,576
Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387
Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
for
Ovarian Cancer
Location: Philadelphia PA, Nashville TN, Peoria IL, St Louis MO,
Sponsor: Nerviano Medical Sciences
Sex: Female
Age: 18+
Code: NCT06930755
Phase1, Recruiting
New Strategies to Enhance Smoking Cessation
for
Smoking Cessation
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18 - 70+
Code: NCT06751927
Recruiting
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
for
Pulmonary Disease, Chronic Obstructive
Location: Bangor ME, Mount Kisco NY, New Windsor NY,
Sponsor: GlaxoSmithKline
Sex: All
Age: 40 - 70+
Code: NCT06961214
Phase3, Recruiting
WIM Exosuit Wearable Soft Robot for Enhancing Walking Activity
for
Stroke, Healthy
Location: Chicago IL
Sponsor: Shirley Ryan AbilityLab
Sex: All
Age: 18 - 70+
Code: NCT07061691
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
for
Endometrial Cancer
Location: St. John's, Scarborough ME, Boston MA, Providence RI,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06952504
Phase3, Recruiting
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
for
Gastric Cancer, Gastroesophageal Junction Cancer
Location: Boston MA, The Bronx NY, New York NY, Hershey PA,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06731478
Phase3, Recruiting
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula